Maze Therapeutics, Inc. Common Stock (MAZE) — Long-term Investment Intensity
Maze Therapeutics, Inc. Common Stock (MAZE) has a Long-term Investment Intensity of 2.5% as of March 2026. Long-term investments of $10.56 Million represent 2.5% of total assets of $419.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Maze Therapeutics, Inc. Common Stock (MAZE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Maze Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Maze Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the intensity stands at 2.5%, reflecting long-term investments of $10.56 Million against total assets of $419.71 Million USD. Explore debt repayment capacity of Maze Therapeutics, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Maze Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Maze Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Maze Therapeutics, Inc. Common Stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 4.6% | $18.11 Million | $397.13 Million | — |